Previous 10 | Next 10 |
2023-03-29 16:25:41 ET OpGen press release ( NASDAQ: OPGN ): Q4 GAAP EPS of -$3.87 misses by $1.87 . Revenue of $0.72M (-49.7% Y/Y). Cash and cash equivalents as of December 31, 2022 were approximately $7.4 million, a decrease compared to the balance at December 31...
Total revenue for 2022 was approximately $2.6 million Balance sheet strengthened by recently closed public offering with gross proceeds of $7.5 million Conference call to be held March 29, 2023 at 4:30 p.m. ET ROCKVILLE, Md., March 29, 2023 (GLOBE NEW...
2023-03-28 17:35:40 ET OpGen ( NASDAQ: OPGN ) is scheduled to announce Q4 earnings results on Wednesday, March 29th, after market close. The consensus EPS Estimate is -$2.00 For further details see: OpGen Q4 2022 Earnings Preview
2023-03-28 17:35:26 ET Major earnings expected after the bell on Wednesday include: RH ( RH ) Planet Labs ( PL ) Beam Global ( BEEM ) Semtech Corporation ( SMTC ) Other earnings slated for release after Wednesday's close include: AXDX , BC...
ROCKVILLE, Md., March 22, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its fourth quarter and full year 2022 financial results after the close of the U.S. finan...
2023-03-10 08:27:32 ET Barnes & Noble Education ( BNED ) +19% on Q3 earnings. Unicycive Therapeutics ( UNCY ) +20% . Stratasys ( SSYS ) +13% on Nano Dimension offers to acquire Stratasys for $18 a share. Heritage Global ( HGBL ) +1...
Approximately 5,000 sq. ft. facility houses laboratory and administrative operations under one location for future growth of business ARESdb, the company’s AMR knowledge database, has grown by 28% in Q1-2023 with now over 130,000 clinical isolates Collaborations with several U.S. s...
ROCKVILLE, Md., Feb. 17, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, today announced that all of the pref...
OpGen's ( NASDAQ: OPGN ) unit Ares Genetics received a patent in China which covers a computer implemented method for the identification and diagnostic use of genomic variants for diagnosis of antibiotic resistant bacteria. The patent number ZL 201680044780.7 granted by Chin...
Best Penny Stock Trading Strategy: How to Create a Watchlist of Potential Stocks Are you looking for penny stocks to buy now? Maybe you’re searching for the top penny stocks to invest in. Whatever your goal is, it’s important to have a solid game plan in place before enterin...
News, Short Squeeze, Breakout and More Instantly...
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...
Gelesis Holdings, Inc. (GLSHQ) is expected to report for Q1 2024 EVmo Inc (YAYO) is expected to report for Q1 2024 Chiba Bank Ltd. ADR (CHBAY) is expected to report for Q4 2024 Spark Networks SE (LOVLQ) is expected to report for Q1 2024 ToughBuilt Industries Inc. (TBLT) is expecte...